Professor Laura Magee
Professor of Women's Health
Research interests
- Women
Biography
Professor Laura Magee graduated MD (Hons) from the University of Toronto (Canada) in 1988. Following clinical training in Toronto (Toronto Western and Mt Sinai Hospitals) to complete her FRCPC (General Internal Medicine, 1992) and subspecialty training (Clinical Pharmacology, Motherisk Program, Hospital for Sick Children), she received funding from the Royal College of Physicians and Surgeons of Canada and the Hospital for Sick Children to undertake her obstetric medicine training with Chris Redman, University of Oxford, while completing her MSc in clinical epidemiology. In 1996, she was appointed as an Assistant Professor of Medicine at the University of Toronto and established the obstetric medicine service at Mt Sinai Hospital. In 2000, she was appointed as a Clinical Assistant Professor at the University of British Columbia and Consultant in Obstetric Medicine at BC Women’s Hospital and General Internal Medicine at Providence Health Care (Vancouver, Canada), with subsequent promotion to Clinical Associate Professor (2005) and Clinical Professor (2011). She returned to the UK in 2015 as Professor of Maternal Medicine, St George’s, University of London, moving to become Professor of Women’s Health, King’s College London in September 2017.
Her research (more than 450 publications to date) has focussed on pregnancy hypertension and medical complications more broadly, using varied study designs, from evidence syntheses to surveys, qualitative research, randomised trials, and implementation studies. Laura has held numerous high-profile leadership positions in the UK and abroad, including Principal Investigator of the international Control of Hypertension In Pregnancy Study (CHIPS) that has changed international guidance in pregnancy; Director of the Canadian Perinatal Network; President of the International Society for the Study of Hypertension in Pregnancy (ISSHP); and Chair of the Maternal Medicine Clinical Study Group, Royal College of Obstetricians and Gynaecologists, and Diabetes in Pregnancy Working Group, Diabetes UK.
Professor Magee has also served as the Founder, Obstetric Medicine Training Programme, University of Toronto, and chaired two national guideline committees in Canada (pregnancy hypertension and fetal neuroprotection). Currently, she is President, International Society for the Study of Hypertension in Pregnancy, President-elect (International Society of Obstetric Medicine). She is an editor (PLOS One) and on the editorial boards of Obstetric Medicine and Pregnancy Hypertension, and a member of the Maternal Morbidity Working Group for the World Health Organization. At King’s College London, she is a member of the King’s Global Health Institute.
With her husband and colleague, Professor von Dadelszen, Professor Magee was the recipient of the International Society for the Study of Hypertension in Pregnancy Chesley Award (2014). In addition, she has received the following awards: Teaching (Outstanding Teaching Award, Mt Sinai Hospital, Toronto), Award of Excellence (Children’s and Women’s Health Centre of BC)); Scholarship (Dr Fred Douglas Memorial Award for Academic Achievement in Internal Medicine and Respirology (University of Toronto), Admission (Alpha-Omega-Alpha Honors Society), Duncan L Gordon Research Fellowship (The Hospital for Sick Children Foundation, Toronto), Detweiler Travelling Fellowship (Royal College of Physicians and Surgeons of Canada), and Scholar Award (Michael Smith Foundation for Health Research, BC).
She is collaborative by nature, and leads through hard work in clinical and research realms. Her experiences span organisations in Canada and the UK, from stand-alone maternity hospitals to tertiary referral centres, always within multidisciplinary teams.
Research
Centre for Conflict & Health Research
Cross disciplinary initiative studying the intersection of global health, security, and political governance in conflict-affected fragile states and regions.
eLIXIR, Born in South London
Addressing relationships between maternal and child physical health and investigating interactions with mental health
Global Maternal Health
Global Maternal Health
Maternal Hypertension
The Hypertension group strategy focuses on improving outcomes for women with hypertension in pregnancy
News
King's researchers evaluate effectiveness of placental growth factor measurement in mid-pregnancy
Among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, PlGF in mid-pregnancy is unhelpful in identifying women and babies...
Scheduled childbirth could cut pre-eclampsia risk by 50%
Latest analysis of data shows that delivering babies earlier at term minimises occurrence of pre-eclampsia in women at increased risk of this important...
Analysis of vaccine uptake among UK women provides valuable insights
Only three-quarters of women of reproductive age were vaccinated against COVID-19 by February 2022, new research has found.
NHS staff share experiences of discrimination during the COVID-19 pandemic
A qualitative study of the experiences of maternity and children’s healthcare professionals during the pandemic has theorised that discrimination amongst NHS...
Review into pre-eclampsia care published
Researchers from King’s College London have published a review of care for women with pre-eclampsia in the New England Journal of Medicine.
Reducing maternal mortality in low- and middle-income countries
New study suggests strongest method to ascertain maternal cause of death.
Thresholds for diagnosing hypertension in pregnancy should not be lowered
New study shows that lowering the threshold for a high blood pressure diagnosis in pregnant women is unlikely to lead to improved outcomes in low-resource...
Team awarded clinical paper of the year for hypertension in pregnancy research
Award from the journal Hypertension recognises paper analysing data from the Control of Hypertension in Pregnancy Study (CHIPS)
Events
Inaugural Lecture: Professors Laura Magee & Peter von Dadelszen
Inspiring talks from some of our brightest minds
Please note: this event has passed.
Spotlight
Improving outcomes of high-risk pregnancy
Addressing an unmet meet need for strategies to identify women and babies at risk of serious complications of pregnancy
Research
Centre for Conflict & Health Research
Cross disciplinary initiative studying the intersection of global health, security, and political governance in conflict-affected fragile states and regions.
eLIXIR, Born in South London
Addressing relationships between maternal and child physical health and investigating interactions with mental health
Global Maternal Health
Global Maternal Health
Maternal Hypertension
The Hypertension group strategy focuses on improving outcomes for women with hypertension in pregnancy
News
King's researchers evaluate effectiveness of placental growth factor measurement in mid-pregnancy
Among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, PlGF in mid-pregnancy is unhelpful in identifying women and babies...
Scheduled childbirth could cut pre-eclampsia risk by 50%
Latest analysis of data shows that delivering babies earlier at term minimises occurrence of pre-eclampsia in women at increased risk of this important...
Analysis of vaccine uptake among UK women provides valuable insights
Only three-quarters of women of reproductive age were vaccinated against COVID-19 by February 2022, new research has found.
NHS staff share experiences of discrimination during the COVID-19 pandemic
A qualitative study of the experiences of maternity and children’s healthcare professionals during the pandemic has theorised that discrimination amongst NHS...
Review into pre-eclampsia care published
Researchers from King’s College London have published a review of care for women with pre-eclampsia in the New England Journal of Medicine.
Reducing maternal mortality in low- and middle-income countries
New study suggests strongest method to ascertain maternal cause of death.
Thresholds for diagnosing hypertension in pregnancy should not be lowered
New study shows that lowering the threshold for a high blood pressure diagnosis in pregnant women is unlikely to lead to improved outcomes in low-resource...
Team awarded clinical paper of the year for hypertension in pregnancy research
Award from the journal Hypertension recognises paper analysing data from the Control of Hypertension in Pregnancy Study (CHIPS)
Events
Inaugural Lecture: Professors Laura Magee & Peter von Dadelszen
Inspiring talks from some of our brightest minds
Please note: this event has passed.
Spotlight
Improving outcomes of high-risk pregnancy
Addressing an unmet meet need for strategies to identify women and babies at risk of serious complications of pregnancy